ctrl K

Atossa Therapeutics Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

0.85

-0.05 (-5.33%)

At close: May 01, 2025, 3:59 PM

0.84

-0.79%

After-hours: May 01, 2025, 07:15 PM EDT

Atossa Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	23K	8K	23K	46.6K	52.79K	44.2K	128.99K	303.48K
Gross Profit	-23K	-8K	-23K	-46.6K	-52.79K	-44.2K	-128.99K	-303.48K
Operating Income	-31.38M	-27.69M	-20.52M	-14.61M	-17.27M	-11.43M	-7.65M	-7.97M
Interest Income	4.34M	877K	6K	n/a	n/a	n/a	n/a	n/a
Pretax Income	-30.09M	-26.96M	-20.61M	-17.83M	-17.24M	-11.4M	-8.12M	-6.37M
Net Income	-30.09M	-26.23M	-20.61M	-21.1M	-17.24M	-11.4M	-8.12M	-6.37M
Selling & General & Admin	14.04M	12.61M	11.31M	8M	10.62M	7.22M	4.86M	6.48M
Research & Development	17.33M	15.08M	9.21M	6.61M	6.65M	4.21M	2.33M	770.43K
Other Expenses	n/a	-146K	-85K	50.8K	25.65K	29.3K	154.00	718.97K
Operating Expenses	31.38M	27.69M	20.52M	14.61M	17.27M	11.43M	7.19M	7.25M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	192.82K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	31.38M	27.69M	20.52M	14.61M	17.27M	11.43M	7.19M	7.25M
Income Tax Expense	n/a	-731K	-213.56K	3.27M	-119.07K	-29.3K	742.46K	-1.76M
Shares Outstanding (Basic)	126.08M	126.62M	116.95M	11.31M	8.5M	4.16M	974.77K	245.6K
Shares Outstanding (Diluted)	126.08M	126.62M	116.95M	11.31M	8.5M	4.16M	974.77K	245.6K
EPS (Basic)	-0.24	-0.21	-0.18	-1.87	-2.03	-2.74	-8.33	-25.93
EPS (Diluted)	-0.24	-0.21	-0.18	-1.87	-2.03	-2.74	-8.33	-25.93
EBITDA	-31.35M	-27.68M	-20.5M	-14.56M	-17.21M	-11.39M	-7.8M	-6.37M
EBIT	-31.38M	-27.69M	-20.52M	-14.61M	-17.27M	-11.43M	-7.93M	-6.37M
Depreciation & Amortization	23K	8K	23K	46.6K	52.79K	44.2K	128.99K	303.48K